Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0036 Transporter Info | ||||
Gene Name | ABCA1 | ||||
Protein Name | ATP-binding cassette sub-family A member 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs12003906 | ||||
Site of GPD | chr9:104883196 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>C / G>T | ||||
Minor Allele Frequency | T=0.0665/333 (Global) | ||||
Allele C | Click to Show/Hide the Full List of Affected Drugs: 3 Drugs in Total | ||||
Atorvastatin | Drug Info | Hyperlipidemias | Correlated with the decreased drug response in patients (compare with Allele G) | [ 1] | |
Pravastatin | Drug Info | Hyperlipidemias | Correlated with the decreased drug response in patients (compare with Allele G) | [ 1] | |
Simvastatin | Drug Info | Hyperlipidemias | Correlated with the decreased drug response in patients (compare with Allele G) | [ 1] | |
Genetic Polymorphism | rs2230806 | ||||
Site of GPD | chr9:104858586 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | C>T | ||||
Minor Allele Frequency | T=0.4397/2202 (Global) | ||||
Genotype TT | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
Pravastatin | Drug Info | Coronary Disease | Correlated with the increased HDL-cholesterol in patients (compare with genotype CC) | [ 2] | |
Fenofibrate | Drug Info | Hypertriglyceridemia | Correlated with the increased drug response in patients (compare with genotype CC) | [ 3] | |
Genotype CT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Fenofibrate | Drug Info | Hypertriglyceridemia | Correlated with the increased drug response in patients (compare with genotype CC) | [ 3] | |
Genetic Polymorphism | rs2230808 | ||||
Site of GPD | chr9:104800523 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | T>C | ||||
Minor Allele Frequency | T=0.4617/2312 (Global) | ||||
Genotype CC | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
Fenofibrate | Drug Info | Hypertriglyceridemia | Correlated with the increased drug response in patients (compare with Genotype TT) | [ 3] | |
References | |||||
1 | Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ Cardiovasc Genet. 2008 Dec;1(2):100-6. | ||||
2 | Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease. Clin Exp Pharmacol Physiol. 2009 May;36(5-6):567-70. | ||||
3 | Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network. Mol Genet Metab. 2010 Jun;100(2):118-22. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.